Black inequity in the US biopharma industry is striking. The most recent US Census indicated 12.1% of the American population are Black, but according to a 2021 Biotechnology Innovation Organization (BIO) survey of roughly 30 pharma and biotech companies, most of whom are based in the US, Black employees account for only 6% of their workforce and fill only 3% of their executive positions.
However, biopharma companies are trying to remedy that situation and indeed are doing so to the extent that a welcome...
Read the full article – start your free trial today!
Join thousands of industry professionals who rely on In Vivo for daily insights
- Start your 7-day free trial
- Explore trusted news, analysis, and insights
- Access comprehensive global coverage
- Enjoy instant access – no credit card required
Already a subscriber?